Skip to main content

Articles

Page 4 of 60

  1. The prevalence of hypertriglyceridemia has been increasing worldwide. Attention is drawn to the fact that the frequency of a special hypertriglyceridemia entity, named chylomicronemia syndrome, is variable amo...

    Authors: György Paragh, Ákos Németh, Mariann Harangi, Maciej Banach and Péter Fülöp
    Citation: Lipids in Health and Disease 2022 21:21
  2. Dietary fatty acids intake affects the composition of erythrocyte fatty acids, which is strongly correlated with glycolipid metabolism disorders. This study aimed at investigating the different effects of mari...

    Authors: Hechun Liu, Feng Wang, Xiaosong Liu, Yulan Xie, Hui Xia, Shaokang Wang and Guiju Sun
    Citation: Lipids in Health and Disease 2022 21:20
  3. Current guidelines for dyslipidemia management recommend that the LDL-C goal be lower than 70 mg/dL. The present study investigated the prognostic significance of visit-to-visit variability in LDL-C, and minim...

    Authors: Chang-Sheng Sheng, Ya Miao, Lili Ding, Yi Cheng, Dan Wang, Yulin Yang and Jingyan Tian
    Citation: Lipids in Health and Disease 2022 21:19
  4. High-density lipoprotein (HDL) plays a critical role in protection against atherosclerosic and cardiovascular disease (ASCVD). In addition to contributing to clearing excess vascular cholesterol, HDL particles...

    Authors: Shelby M. Flaherty, Elizabeth K. Wood, Carol D. Ryff, Gayle D. Love, Theodoros Kelesidis, Loni Berkowitz, Guadalupe Echeverría, Katherine Rivera, Attilio Rigotti and Christopher L. Coe
    Citation: Lipids in Health and Disease 2022 21:18
  5. Biochemical markers are crucial for determining risk in coronary artery disease (CAD) patients; however, the relationship between fasting blood glucose to high-density lipoprotein cholesterol (FG/HDL-C) ratio ...

    Authors: Simin Deng, Zhaojun Wang, Yifeng Zhang, Ying Xin, Cheng Zeng and Xinqun Hu
    Citation: Lipids in Health and Disease 2022 21:17
  6. Accumulating evidence suggests sleep duration may be involved in metabolic regulation. However, studies regarding the association with the early stage of the metabolic disease are limited, and the findings wer...

    Authors: Lili Huang, Zichong Long, Gang Xu, Yiting Chen, Rong Li, Yanlin Wang and Shenghui Li
    Citation: Lipids in Health and Disease 2022 21:16
  7. Bile acids (BAs) not only play an important role in lipid metabolism and atherosclerosis but also have antiapoptotic and neuroprotective effects. However, few studies have focused on the relationship of the to...

    Authors: Lingling Huang, Ge Xu, Rong Zhang, Yadong Wang, Jiahui Ji, Fengdan Long and Yaming Sun
    Citation: Lipids in Health and Disease 2022 21:15
  8. Calcific aortic valve disease (CAVD) has a substantial and increasing burden in the ageing population with occult onset.Present study aimed to assess association of clinical characteristics of these patients a...

    Authors: Cong Liu, Haifeng Liu and Ting Xie
    Citation: Lipids in Health and Disease 2022 21:14
  9. Benzo [a] pyrene (BaP), a potent carcinogen, has been proved that it has toxicological effects via activation the aryl hydrocarbon receptor (AhR) pathway. AhR can participate in regulating lipogenesis and lipo...

    Authors: Wei Lou, Meng-di Zhang, Qi Chen, Tu-Ya Bai, Yu-Xia Hu, Feng Gao, Jun Li, Xiao-Li Lv, Qian Zhang and Fu-Hou Chang
    Citation: Lipids in Health and Disease 2022 21:13
  10. Diabetic retinopathy (DR) is the primary oculopathy causing blindness in diabetic patients. Currently, there is increasing interest in the role of lipids in the development of diabetic retinopathy, but it rema...

    Authors: Yongyan Shan, Qian Wang, Yitong Zhang, Xuewei Tong, Shengdan Pu, Yuxin Xu and Xinyuan Gao
    Citation: Lipids in Health and Disease 2022 21:12
  11. Sitosterolemia is a lipid disorder characterized by the accumulation of phytosterols in plasma and organs, caused by mutations in the ABCG5 and/or ABCG8 genes. The disease is frequently misdiagnosed and mistreate...

    Authors: Zhizi Zhou, Xueying Su, Yanna Cai, Tzer Hwu Ting, Wen Zhang, Yunting Lin, Aijing Xu, Xiaojian Mao, Chunhua Zeng, Li Liu and Xiuzhen Li
    Citation: Lipids in Health and Disease 2022 21:11
  12. Lipocalin-2 (LCN2) has a critical effect on obesity as well as its associated comorbidities. The present study focused on analyzing serum LCN2 levels of obese patients with nonalcoholic fatty liver disease (NA...

    Authors: Jiaqi Chen, Shihui Lei, Yueye Huang, Xiaojuan Zha, Lei Gu, Donglei Zhou, Jun Li, Feng Liu, Nannan Li, Lei Du, Xiu Huang, Ziwei Lin, Le Bu and Shen Qu
    Citation: Lipids in Health and Disease 2022 21:10
  13. The discovery of the endocannabinoidome (eCBome) is evolving gradually with yet to be elucidated functional lipid mediators and receptors. The diet modulates these bioactive lipids and the gut microbiome, both...

    Authors: Jyoti Sihag and Vincenzo Di Marzo
    Citation: Lipids in Health and Disease 2022 21:9
  14. Lipid accumulation product (LAP) and cardiometabolic index (CMI) are two novel obesity-related indexes associated with enhancing metabolic disease (MD) risk. Current evidences suggest that the differences in s...

    Authors: Yiting Liu and Wei Wang
    Citation: Lipids in Health and Disease 2022 21:8
  15. A novel classification has been introduced to promote precision medicine in diabetes. The current study aimed to investigate the relationship between leptin and resistin levels with novel refined subgroups in ...

    Authors: Xuemin Peng, Jiaojiao Huang, Huajie Zou, Bei Peng, Sanshan Xia, Kun Dong, Nan Sun, Jing Tao and Yan Yang
    Citation: Lipids in Health and Disease 2022 21:7
  16. Phosphatidylinositol 4-phosphate 5-kinase type I c (PIP5K1c) catalyses the synthesis of phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) by phosphorylating phosphatidylinositol 4 phosphate, which play...

    Authors: Guan Huang, Cuishan Yang, Sheng Guo, Miaoling Huang, Liping Deng, Ying Huang, Puxin Chen, Feng Chen and Xiaohong Huang
    Citation: Lipids in Health and Disease 2022 21:6
  17. Recent advances in society have resulted in the emergence of both hyperlipidemia and obesity as life-threatening conditions in people with implications for various types of diseases, such as cardiovascular dis...

    Authors: Bo Wang, Heng Wang, Yuancheng Li and Lei Song
    Citation: Lipids in Health and Disease 2022 21:5
  18. Small, dense low-density lipoprotein (sd-LDL) increases in type 2 diabetes patients and causes arteriosclerosis. Non–high-density-lipoprotein cholesterol (non–HDL-C) is thought to be useful for predicting arte...

    Authors: Gen Ouchi, Ichiro Komiya, Shinichiro Taira, Tamio Wakugami and Yusuke Ohya
    Citation: Lipids in Health and Disease 2022 21:4
  19. The risk of liver fibrosis in non-alcoholic fatty liver disease (NAFLD) can be easily evaluated by noninvasive scoring systems, of which the NAFLD fibrosis score (NFS) is the most commonly used. Proprotein con...

    Authors: Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu and Jian-Jun Li
    Citation: Lipids in Health and Disease 2022 21:3
  20. Authors: Noriko Suzuki-Kemuriyama, Akari Abe, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima and Dai Nakae
    Citation: Lipids in Health and Disease 2022 21:2

    The original article was published in Lipids in Health and Disease 2020 19:251

  21. High levels of apolipoprotein C3 (APOC3) can lead to hypertriglyceridemia, which increases the risk of cardiovascular disease. We aim to create APOC3-knockout (KO) rabbits and explore the effects of APOC3 dele...

    Authors: Yiwen Zha, Yaoyao Lu, Ting Zhang, Kunning Yan, Wenwen Zhuang, Jingyan Liang, Yong Cheng and Yingge Wang
    Citation: Lipids in Health and Disease 2021 20:180
  22. Lipids have a wide variety and vital functions. Lipids play roles in energy metabolism, intracellular and extracellular signal traffic, and transport of fat-soluble vitamins. Also, they form the structure of t...

    Authors: Erkan Cure and Medine Cumhur Cure
    Citation: Lipids in Health and Disease 2021 20:179
  23. Cordyceps militaris is cultured widely as an edible mushroom and accumulating evidence in mice have demonstrated that the polysaccharides of Cordyceps species have lipid-lowering effects. However, lipid metabolis...

    Authors: Wen-Qian Yu, Fan Yin, Nuo Shen, Ping Lin, Bin Xia, Yan-Jie Li and Shou-Dong Guo
    Citation: Lipids in Health and Disease 2021 20:178
  24. Hypertriglyceridemia can occur in lymphoproliferative disorders. Infectious mononucleosis is a self-limiting, benign lymphoproliferative disorder. This study aimed to investigate the serum triglyceride concent...

    Authors: Emilio-Manuel Páez-Guillán, Joaquín Campos-Franco, Rosario Alende, Yago Garitaonaindía and Arturo González-Quintela
    Citation: Lipids in Health and Disease 2021 20:177
  25. To date, there have no study comparing the associations between TyG index and HOMA-IR on the risk of incident albuminuria. Accordingly, the objective of the present study is to use discordance analysis to eval...

    Authors: Wei Gao, Jialu Wang, Yan Chen, Hongmei Qiao, Xiaozhong Qian, Zhuojun Xin, Zhiyun Zhao, Tiange Wang, Yu Xu, Min Xu, Yufang Bi, Mian Li and Jinli Gao
    Citation: Lipids in Health and Disease 2021 20:176
  26. Obstructive sleep apnea (OSA) is a disorder with a significant risk for cardiovascular diseases. Dyslipidemia and redox imbalance belong to potential mechanisms linking OSA with the development of vascular dis...

    Authors: Branislav Kollar, Pavel Siarnik, Alzbeta Hluchanova, Katarina Klobucnikova, Imrich Mucska, Peter Turcani, Zuzana Paduchova, Barbora Katrencikova, Maria Janubova, Katarina Konarikova, Lubica Argalasova, Stanislav Oravec and Ingrid Zitnanova
    Citation: Lipids in Health and Disease 2021 20:175
  27. Familial partial lipodystrophy (FPLD) is a rare disease characterized by selective loss of peripheral subcutaneous fat, associated with dyslipidemia and diabetes mellitus. Reductions in circulating levels of A...

    Authors: Maria C. Foss-Freitas, Baris Akinci, Adam Neidert, Victoria J. Bartlett, Eunju Hurh, Ewa Karwatowska-Prokopczuk and Elif A. Oral
    Citation: Lipids in Health and Disease 2021 20:174
  28. AdipoR1 and AdipoR2 (AdipoRs) are plasma membrane proteins often considered to act as adiponectin receptors with a ceramidase activity. Additionally, the AdipoRs and their yeast and C. elegans orthologs are emerg...

    Authors: Mario Ruiz, Marcus Henricsson, Jan Borén and Marc Pilon
    Citation: Lipids in Health and Disease 2021 20:173
  29. Authors: Afaf El-Ansary, Manan Alhakbany, Abeer Aldbass, Hanan Qasem, Sarah Al-Mazidi, Ramesa Shafi Bhat and Laila Al-Ayadhi
    Citation: Lipids in Health and Disease 2021 20:172

    The original article was published in Lipids in Health and Disease 2021 20:155

  30. The effect of comorbid hypertriglyceridemia (HTG) and abdominal obesity (AO) on acute pancreatitis (AP) remains unclear. The aim of this study was to explore the effect of comorbid HTG and AO and discuss which...

    Authors: Xiaoxi Yang, Jiajun He, Shuli Ma, Tingting Wang, Quping Zhu, Fei Cao, Yuanhao Li, Chuting Yang, Chaowu Chen, Guotao Lu, Lianghao Hu, Jun Liu and Weiwei Chen
    Citation: Lipids in Health and Disease 2021 20:171
  31. Dyslipoproteinemias can be classified by their distinct lipoprotein patterns, which helps determine atherosclerotic cardiovascular disease (ASCVD) risk and directs lipid management but this has required advanc...

    Authors: Maureen Sampson, Rami A. Ballout, Daniel Soffer, Anna Wolska, Sierra Wilson, Jeff Meeusen, Leslie J. Donato, Erica Fatica, James D. Otvos, Eliot A. Brinton, Robert S. Rosenson, Peter Wilson, Marcelo Amar, Robert Shamburek, Sotirios K. Karathanasis and Alan T. Remaley
    Citation: Lipids in Health and Disease 2021 20:170
  32. 15-lipoxygenase is one of the key enzymes for the metabolism of unsaturated fatty acids that its manipulation has been proposed recently as a new molecular target for regulating cancer cell growth. Aberrant ex...

    Authors: Mohammad Amin Vaezi, Banafsheh Safizadeh, Amir Reza Eghtedari, Seyedeh Sara Ghorbanhosseini, Mostafa Rastegar, Vahid Salimi and Masoumeh Tavakoli-Yaraki
    Citation: Lipids in Health and Disease 2021 20:169
  33. Serum lipid abnormalities are generally considered as a major risk factor for type 2 diabetes mellitus (T2DM). However, evidence for the effect of long-term serum lipid fluctuations on future T2DM probability ...

    Authors: Qian Sun, Jingchao Liu, Lei Wu, Yue Sun, Jianrong Jin, Sudan Wang, Jing Wu, Yang Jing, Hui Zhou and Chen Dong
    Citation: Lipids in Health and Disease 2021 20:168
  34. Osteonecrosis of the femoral head (ONFH) is a common but intractable disease that appears to involve lipid metabolic disorders. Although numerous studies have demonstrated that high blood levels of low-density...

    Authors: Xin-Yuan Wang, Tian-Le Ma, Kang-Ning Chen, Zhi-Ying Pang, Hao Wang, Jun-Ming Huang, Guo-Bin Qi, Chen-Zhong Wang, Zeng-Xin Jiang, Lin-Jing Gong, Zhe Wang, Chang Jiang and Zuo-Qin Yan
    Citation: Lipids in Health and Disease 2021 20:167
  35. Laparoscopic colorectal surgery causes a lower stress response than open surgery. Adiponectin is mainly derived from adipocytes and has antidiabetic, antioxidative, and anti-inflammatory capabilities. The obje...

    Authors: Wenjiao Shi, Jian Lou, Xiaodan Zhang, Yun Ji, Xiaojian Weng and Jianer Du
    Citation: Lipids in Health and Disease 2021 20:166
  36. Anlotinib, a small molecule for multi-target tyrosine kinase inhibition, is the third or further line of defense for treatment of non-small cell lung cancer (NSCLC). Findings from an ALTER0303 phase III trial ...

    Authors: Mengqiu Tang, Chao Song, Yaowen Zhang, Xiaoyu Xu, Chen Wang, Zhanchun Zhang and Tian Chen
    Citation: Lipids in Health and Disease 2021 20:165
  37. Quercetin (QUE) is a flavonol reported with anti-inflammatory and antioxidant activities, and previous results from the group of this study have demonstrated its neuroprotective effect against lipopolysacchari...

    Authors: Xin-Ran Gao, Zheng Chen, Ke Fang, Jing-Xian Xu and Jin-Fang Ge
    Citation: Lipids in Health and Disease 2021 20:164
  38. The relationship between body mass index (BMI) and low-density lipoprotein cholesterol (LDL-C) has not been clearly elucidated in middle-aged and older adults. This study aimed to evaluate the non-linear dose-...

    Authors: Haibin Li, Jiahui Ma, Deqiang Zheng, Xia Li, Xiuhua Guo, Jing Wang and Pixiong Su
    Citation: Lipids in Health and Disease 2021 20:162
  39. Triglyceride glucose-body mass index (TyG-BMI) has been recommended as an alternative indicator of insulin resistance. However, the association between TyG-BMI and pre-diabetes remains to be elucidated.

    Authors: Chunyuan Jiang, Ruijuan Yang, Maobin Kuang, Meng Yu, Mingchun Zhong and Yang Zou
    Citation: Lipids in Health and Disease 2021 20:161
  40. The high drug resistance and metabolic reprogramming of clear cell renal cell carcinoma (ccRCC) are considered responsible for poor prognosis. In-depth research at multiple levels is urgently warranted to illu...

    Authors: Wen Li, Xiaobin Wang, Xianbin Zhang, Peng Gong, Degang Ding, Ning Wang and Zhifeng Wang
    Citation: Lipids in Health and Disease 2021 20:160
  41. Non-high-density lipoprotein cholesterol (non-HDL-C) may be an independent risk factor for cardio-cerebrovascular disease (CVD); however, the cutoff level in patients on maintenance hemodialysis (MHD) is unknown.

    Authors: Denggui Luo, Yueming Luo, Yanhong Zou, Yuanzhao Xu, Bo Fu, Dong Yang, Jun Yang, Cai Xu, Shuyi Ling, Shunmin Li and Airong Qi
    Citation: Lipids in Health and Disease 2021 20:159
  42. Increased evidence has reported the association of genetic polymorphisms of Apolipoprotein E (APOE) with serum lipids. However, few studies have explored the combined effects of APOE, gender, and age.

    Authors: Xiaofeng Liu, Qingwen Lin, Kengna Fan, Minjie Tang, Weiqing Zhang, Bin Yang and Qishui Ou
    Citation: Lipids in Health and Disease 2021 20:158
  43. To determine the effect of genetic polymorphism of drug transporters on the efficacy of treatment with Rosuvastatin, Atorvastatin and Simvastatin in patients with hyperlipidemia.

    Authors: Andrey Sivkov, Natalya Chernus, Roman Gorenkov, Sergey Sivkov, Svetlana Sivkova and Tamara Savina
    Citation: Lipids in Health and Disease 2021 20:157
  44. Rash, photosensitivity, erythema multiforme, and the acute generalized exanthematous pustulosis (AGEP) are relatively uncommon adverse reactions of drugs. To date, the etiology is not well understood and indiv...

    Authors: Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk and Hans-Peter Deigner
    Citation: Lipids in Health and Disease 2021 20:156
  45. Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and restricted and repetitive behaviors. Neuroinflammation and abnormal lipid mediators have b...

    Authors: Afaf El-Ansary, Manan Alhakbany, Abeer Aldbass, Hanan Qasem, Sarah Al-Mazidi, Ramesa Shafi Bhat and Laila Al-Ayadhi
    Citation: Lipids in Health and Disease 2021 20:155

    The Correction to this article has been published in Lipids in Health and Disease 2021 20:172

  46. We investigated the role of ANGPTL3 and ANGPTL4 in atherosclerosis development and determined whether plasma concentrations of ANGPTL3 and ANGPTL4 are related to the degree of coronary stenosis.

    Authors: Ting Sun, Wanlin Zhan, Lijiang Wei, Zuojun Xu, Li Fan, Yang Zhuo, Changqian Wang and Junfeng Zhang
    Citation: Lipids in Health and Disease 2021 20:154
  47. Despite recent advances in recognizing more reliable indicators to estimate the coronary artery disease (CAD) patients’ response to treatment and prognosis, less attention has been paid to evaluating them in c...

    Authors: Marjan Mahdavi-Roshan, Arsalan Salari, Azin Vakilpour, Amir Savar Rakhsh and Zeinab Ghorbani
    Citation: Lipids in Health and Disease 2021 20:153

Annual Journal Metrics